• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人使用催眠药。有哪些值得关注的问题?

Hypnotics in the elderly. What cause for concern?

作者信息

Morgan K

机构信息

Department of Health Care of the Elderly, University of Nottingham Medical School, England.

出版信息

Drugs. 1990 Nov;40(5):688-96. doi: 10.2165/00003495-199040050-00004.

DOI:10.2165/00003495-199040050-00004
PMID:2292231
Abstract

At any age hypnotic drug use can give rise to 3 major problems: unwanted effects on daytime mood and behaviour associated with drug consumption; rebound effects associated with drug withdrawal; and dependency associated with long term drug use. For 2 reasons elderly hypnotic users are both more vulnerable and more exposed to each of these problems. Firstly, age-related changes in pharmacodynamic and pharmacokinetic processes amplify the behavioural impact of many hypnotics; and secondly, age-related changes in the structure and quality of sleep tend to increase the demand for, and the long term use of, sedative hypnotic compounds in old age. The existence of physical illness, cognitive impairment, or daytime behaviour already compromised by normal aging processes further increases the likelihood of hypnotic drugs detrimentally affecting well-being in later life. These important causes for concern emphasise the need for 2 separate clinical responses: the need for greater circumspection in the choice and use of hypnotic drugs among elderly patients, and the need for a more broadly based clinical approach to the management of sleep problems in old age.

摘要

在任何年龄,使用催眠药物都会引发3个主要问题:与药物服用相关的对日间情绪和行为的不良影响;与药物戒断相关的反跳效应;以及与长期药物使用相关的依赖性。出于两个原因,老年催眠药物使用者更容易受到这些问题的影响,且接触这些问题的机会更多。首先,药效学和药代动力学过程中与年龄相关的变化会放大许多催眠药物的行为影响;其次,睡眠结构和质量与年龄相关的变化往往会增加老年人对镇静催眠化合物的需求以及长期使用。身体疾病、认知障碍或正常衰老过程已经损害的日间行为的存在,进一步增加了催眠药物对晚年幸福感产生不利影响的可能性。这些令人担忧的重要原因强调了两种不同临床应对措施的必要性:在老年患者中选择和使用催眠药物时需要更加谨慎,以及需要采用更广泛的临床方法来管理老年人的睡眠问题。

相似文献

1
Hypnotics in the elderly. What cause for concern?老年人使用催眠药。有哪些值得关注的问题?
Drugs. 1990 Nov;40(5):688-96. doi: 10.2165/00003495-199040050-00004.
2
Sedative-hypnotic drug use among community-dwelling elderly in Taiwan.台湾社区老年人镇静催眠药物使用情况。
Int Psychogeriatr. 2018 Jul;30(7):957-965. doi: 10.1017/S1041610217002940. Epub 2018 Mar 21.
3
Main neuroendocrine features and therapy in primary sleep troubles.原发性睡眠障碍的主要神经内分泌特征及治疗
Rev Med Chir Soc Med Nat Iasi. 2012 Jul-Sep;116(3):862-6.
4
Zaleplon: a review of its use in the treatment of insomnia.扎来普隆:用于治疗失眠的综述
Drugs. 2000 Aug;60(2):413-45. doi: 10.2165/00003495-200060020-00014.
5
[The elderly, sleep habits and use of psychotropic drugs by the French population].[法国人口中的老年人、睡眠习惯与精神药物使用情况]
Encephale. 1996 Sep-Oct;22(5):337-50.
6
Effects of the use of hypnotics on cognition.催眠药物使用对认知的影响。
Prog Brain Res. 2011;190:89-103. doi: 10.1016/B978-0-444-53817-8.00005-0.
7
Sedative-hypnotic drug use and ageing.镇静催眠药物的使用与衰老
Arch Gerontol Geriatr. 1983 Nov;2(3):181-99. doi: 10.1016/0167-4943(83)90022-5.
8
Hypnotics. Options to help your patients stop.催眠药。帮助你的患者停药的选择。
Aust Fam Physician. 2000 Oct;29(10):939-44.
9
A procedure for withdrawal of sleep medication in elderly women who have been long-term users.针对长期使用睡眠药物的老年女性的撤药程序。
J Gerontol Nurs. 1998 Sep;24(9):20-8; quiz 50-1. doi: 10.3928/0098-9134-19980901-10.
10
Study on withdrawal of hypnotics: questionnaire on hypnotic use and its withdrawal.催眠药撤药研究:催眠药使用及其撤药调查问卷。
Psychiatry Clin Neurosci. 2001 Jun;55(3):209-10. doi: 10.1046/j.1440-1819.2001.00828.x.

引用本文的文献

1
Moderating Benzodiazepine Use in the Elderly: Curbing physicians' prescribing practices.适度控制老年人使用苯二氮䓬类药物:抑制医生的处方行为。
Can Fam Physician. 1992 Oct;38:2459-543.
2
A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers.一项关于唑吡坦缓释片对健康老年志愿者残留精神运动和认知影响的双盲、安慰剂对照研究。
Br J Clin Pharmacol. 2006 Nov;62(5):538-45. doi: 10.1111/j.1365-2125.2006.02705.x.
3
[Prevalence of insomnia and use of psychodrugs among elderly in a basic health area in Cuenca].

本文引用的文献

1
Adverse reactions to prescribed drugs in the elderly: a multicentre investigation.老年人处方药不良反应:一项多中心调查。
Age Ageing. 1980 May;9(2):73-80. doi: 10.1093/ageing/9.2.73.
2
Systematic review of the benzodiazepines. Guidelines for data sheets on diazepam, chlordiazepoxide, medazepam, clorazepate, lorazepam, oxazepam, temazepam, triazolam, nitrazepam, and flurazepam. Committee on the Review of Medicines.苯二氮䓬类药物的系统评价。地西泮、氯氮䓬、美达西泮、氯氮䓬钾、劳拉西泮、奥沙西泮、替马西泮、三唑仑、硝西泮和氟西泮的数据表指南。药品审评委员会。
Br Med J. 1980 Mar 29;280(6218):910-2. doi: 10.1136/bmj.280.6218.910.
3
Sleep-wake disorders in the elderly: polysomnographic analysis.
[昆卡市一个基本卫生区域内老年人失眠症患病率及精神药物使用情况]
Aten Primaria. 2000 Apr 15;25(6):400-4. doi: 10.1016/s0212-6567(00)78530-1.
4
Clinical management of patients with insomnia. The role of zopiclone.失眠患者的临床管理。佐匹克隆的作用。
Pharmacoeconomics. 1996;10 Suppl 1:29-38. doi: 10.2165/00019053-199600101-00006.
5
Hypnotics. Drug selection by means of the System of Objectified Judgement Analysis (SOJA) method.催眠药。采用客观判断分析系统(SOJA)方法进行药物选择。
Pharmacoeconomics. 1996 Aug;10(2):152-63. doi: 10.2165/00019053-199610020-00007.
6
Zopiclone: is there any dependence and abuse potential?佐匹克隆:是否存在依赖性和滥用可能性?
J Neurol. 1997 Apr;244(4 Suppl 1):S18-22. doi: 10.1007/BF03160567.
7
Factors associated with low cognitive performance in general practice.
Eur Arch Psychiatry Clin Neurosci. 1994;244(2):53-8. doi: 10.1007/BF02193519.
8
Pharmacotherapy of insomnia: practice and prospects.失眠的药物治疗:实践与展望
Pharm World Sci. 1995 May 26;17(3):67-75. doi: 10.1007/BF01875434.
9
Guidelines for the rational use of benzodiazepines. When and what to use.苯二氮䓬类药物合理使用指南。何时使用及使用何种药物。
Drugs. 1994 Jul;48(1):25-40. doi: 10.2165/00003495-199448010-00004.
10
Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II).老年人中抗焦虑药和催眠药的临床药代动力学。治疗考量(第二部分)
Clin Pharmacokinet. 1991 Oct;21(4):262-73. doi: 10.2165/00003088-199121040-00003.
老年人的睡眠-觉醒障碍:多导睡眠图分析
J Am Geriatr Soc. 1981 Jul;29(7):289-96. doi: 10.1111/j.1532-5415.1981.tb01267.x.
4
Hypnotic usage in residential homes for the elderly: a prevalence and longitudinal analysis.养老院中催眠药物的使用情况:一项患病率及纵向分析。
Age Ageing. 1982 Nov;11(4):229-34. doi: 10.1093/ageing/11.4.229.
5
Quazepam and flurazepam: long-term use and extended withdrawal.夸西泮和氟西泮:长期使用及延长撤药期
Clin Pharmacol Ther. 1982 Dec;32(6):781-8. doi: 10.1038/clpt.1982.236.
6
Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects.氟西泮对无症状受试者睡眠呼吸紊乱及夜间氧饱和度下降的影响。
Am J Med. 1982 Aug;73(2):239-43. doi: 10.1016/0002-9343(82)90185-1.
7
The pharmacokinetics of psychotropic medication in the elderly: a review.老年人精神药物的药代动力学:综述
J Clin Psychiatry. 1981 Oct;42(10):374-85.
8
Factors affecting the consumption of psychotropic drugs.影响精神药物消费的因素。
Psychol Med. 1981 Aug;11(3):551-60. doi: 10.1017/s0033291700052867.
9
Pharmacokinetics and metabolism of zopiclone.
Pharmacology. 1983;27 Suppl 2:76-91. doi: 10.1159/000137914.
10
Plasma concentrations and central nervous system effects of the new hypnotic agent zopiclone in patients with chronic liver disease.新型催眠药佐匹克隆在慢性肝病患者中的血浆浓度及对中枢神经系统的影响。
Br J Clin Pharmacol. 1983 Sep;16(3):259-65. doi: 10.1111/j.1365-2125.1983.tb02159.x.